Eye diseases in chronic kidney disease: A nationwide longitudinal case–control study in Sweden
Clinical & Experimental Ophthalmology · 2025
DOI: 10.1111/ceo.14464 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Clinical & Experimental Ophthalmology, 2025. Verfasst von Pablo Ballester Dolz und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Faculty of Medicine and Health, Orebro University, Orebro, Sweden. Hauptthemen laut MEDLINE: Renal Insufficiency, Chronic, Eye Diseases. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Chronic kidney disease (CKD) is a growing health issue that is becoming more prevalent globally, increasing financial cost on healthcare systems. The purpose of this study is to investigate the incidence of eye diseases in patients diagnosed with CKD in Sweden and to evaluate which eye diseases are most likely to develop.
Methods
A longitudinal population‐based retrospective case–control study was conducted including all individuals diagnosed with chronic kidney disease during the time period 2001–2019. A total of 19 455 cases and 38 890 controls were included. For each case, two controls were matched with the same sex, age, and county of residence.
Results
CKD patients had a significantly higher risk of contracting any eye disease compared to individuals without kidney disease HR 1.73 (CI 1.67–1.79), with an elevated risk for all blocks of diagnoses except for glaucoma HR 0.95 (CI 0.85–1.06). However, this condition developed earlier in cases than in controls. Subanalyses showed an increased risk for chronic eye disease patients to develop cataract HR 1.70 (CI 1.63–1.78), other retinal disorders HR 1.86 (CI 1.72–2.02), and retinal vascular occlusions HR 2.08 (CI 1.73–2.51). In general, diagnosis of an eye disease occurred earlier in cases than controls.
Conclusions
The results from this study suggest that CKD patients have an increased risk to develop eye disease. Ocular disease seems to develop considerably earlier in CKD, even without staging the severity of the disease, with particularly high risk of developing retinal diseases and cataracts. Screening for eye disease in CKD should be considered.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Ophthalmology, Faculty of Medicine and Health, Orebro University, Orebro, Sweden.
- School of Medical Sciences, Orebro University, Orebro, Sweden.
- Department of Medical Sciences, Occupational and Environmental Medicine, Uppsala University, Uppsala, Sweden.
- Department of Occupational and Environmental Medicine, Uppsala University Hospital, Uppsala, Sweden.
- Department of Occupational and Environmental Medicine, Faculty of Medicine and Health, Orebro University, Orebro, Sweden.
ORCID-Profile: Pablo Ballester Dolz, Karim Makdoumi
Zitieren
APA
Ballester Dolz, P., Ålander, K., Smedberg, P., Vihlborg, P., Bryngelsson, I. L., Westerlund, J., & Makdoumi, K. (2025). Eye diseases in chronic kidney disease: A nationwide longitudinal case–control study in Sweden. Clinical & Experimental Ophthalmology. https://doi.org/10.1111/ceo.14464
Vancouver
Ballester Dolz P, Ålander K, Smedberg P, Vihlborg P, Bryngelsson IL, Westerlund J, et al. Eye diseases in chronic kidney disease: A nationwide longitudinal case–control study in Sweden. Clinical & Experimental Ophthalmology. 2025. doi:10.1111/ceo.14464
BibTeX
@article{BallesterDolz2025,
author = {Ballester Dolz, Pablo and Ålander, Karin and Smedberg, Petra and Vihlborg, Per and Bryngelsson, Ing-Liss and Westerlund, Jessica and Makdoumi, Karim},
title = {Eye diseases in chronic kidney disease: A nationwide longitudinal case–control study in Sweden},
journal = {Clinical & Experimental Ophthalmology},
year = {2025},
doi = {10.1111/ceo.14464}
}
EUVIMED